ICMR Approves Two Home-Based Rapid Antigen Test Kits For COVID-19 Testing
The Indian Council of Medical Research (ICMR) has approved two home-based Rapid Antigen Test kits, to be used only in symptomatic individuals and immediate contacts of laboratory confirmed positive cases.
Accordingly, the ICMR has approved CoviSelf, manufactured by Mylab Discovery Solutions Ltd, Pune, and the PanBio COVID-19 Antigen Rapid Test Device, devloped by Chicago-based Abbott Rapid Diagnostics. The latter's provisional approval has been accorded till 5 July 2021.
"Indiscriminate testing is not advised. Home testing should be conducted as per the procedure described by the manufacturer in the user manual. Home testing by RAT is advised only in symptomatic individuals and immediate contacts of laboratory confirmed positive cases," the ICMR said.
All positive individuals are advised to follow home isolation and care as per the ICMR and Ministry of Health and Family Welfare (MoH&FW) protocols.
The symptomatic individuals who test negative by RAT should get themselves immediately tested by RTPCR. This is especially important as the RATs are likely to miss few positive cases presenting with a low viral load.
All RAT negative symptomatic individuals may be treated as suspect COVID-19 cases and are advised to follow the ICMR/MoH&FW home isolation protocol while awaiting the RTPCR test result, it said.
All results may be interpreted as per the protocols laid down by the manufacturer in the user manual . Manufacturer's instructions must be strictly followed for disposal of the test kit, swab and other materials.
(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.